Back to Results

Rhoen Klinikum AG ADR (RKAGY)

Rhoen Klinikum AG ADR is a depositary receipt listed on OTC Markets representing common stock in RHÖN-KLINIKUM Aktiengesellschaft. The underlying issuer is a healthcare provider operating in Germany through a network that includes acute hospitals, medical care centers, and rehabilitation hospitals. Its services cover inpatient, semi-inpatient, and outpatient care. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is headquartered in Bad Neustadt an der Saale, Germany.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-RKAG.Y
$10.37
27.1% Upside
Undervalued
Not available
Not available
Great
0.8%
22.7x
0.7x
0.5x
1.096 B
898.7 M
11.2%
5.5%
9.9
31.8%
29.7%
Valuation • Fair Value

Rhoen Klinikum AG ADR (OTC-RKAG.Y) Fair Value by Valuation Model

Review the available estimates for Rhoen Klinikum AG ADR (OTC-RKAG.Y), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$10.37

Estimated upside of 27.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$11.68

Discounted cash flow valuation reference.

Ben Graham Formula Value

$4.56

Classic Ben Graham valuation formula reference.

DDM Fair Value

$10.25

Dividend discount model valuation reference.

EPV Fair Value

$5.78

Earnings power value estimate.

Comps Fair Value

$9.84

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 7 available valuation references for Rhoen Klinikum AG ADR (OTC-RKAG.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Rhoen Klinikum AG ADR (OTC-RKAG.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.315 B

Current operating scale indicator.

Revenue Forecast

2.049 B

Forward revenue estimate.

EBITDA

127.5 M

Current operating profitability reference.

EBITDA Forecast

139.7 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Rhoen Klinikum AG ADR (OTC-RKAG.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Rhoen Klinikum AG ADR (OTC-RKAG.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

9

Relatively strong quality score.

Beneish M-Score

-2.73

No elevated caution signal from this screen.

Altman Z-Score

9.9

Relatively strong balance-sheet zone.

FCF / Net Income

29.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Rhoen Klinikum AG ADR (OTC-RKAG.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Rhoen Klinikum AG ADR (OTC-RKAG.Y)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.8%

Current income yield reference.

Payout Ratio

31.8%

Dividend payout reference.

How to read events and dividends

Review the currently available dividend data for Rhoen Klinikum AG ADR (OTC-RKAG.Y). No upcoming company event date is included in the latest data.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Rhoen Klinikum AG ADR (OTC-RKAG.Y) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Rhoen Klinikum AG ADR (OTC-RKAG.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Rhoen Klinikum AG ADR (OTC-RKAG.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Rhoen Klinikum AG ADR (OTC-RKAG.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Rhoen Klinikum AG ADR (OTC-RKAG.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Rhoen Klinikum AG ADR (OTC-RKAG.Y) Stock FAQ

Data-supported answers about Rhoen Klinikum AG ADR (OTC-RKAG.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$10.37
Estimated upside 27.1%
Valuation Rating
Undervalued
Estimated upside of 27.1%
Financial Health
Great
Current financial-health read

The current fair value estimate for Rhoen Klinikum AG ADR (OTC-RKAG.Y) is $10.37. This implies an estimated upside of 27.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 27.1% versus the current market price.

The current financial health read for Rhoen Klinikum AG ADR (OTC-RKAG.Y) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 0.8%.

The current P/E ratio listed for Rhoen Klinikum AG ADR (OTC-RKAG.Y) is 22.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Rhoen Klinikum AG ADR is 1.096 B.

The current enterprise value listed for Rhoen Klinikum AG ADR is 898.7 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Rhoen Klinikum AG ADR is OTC-RKAG.Y, and the stock is listed on OTC Markets.

Rhoen Klinikum AG ADR (OTC-RKAG.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Rhoen Klinikum AG ADR is 11.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Rhoen Klinikum AG ADR is 5.5%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Undervalued Market Cap 334.8 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 111.4 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 103.9 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 94.854 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 87.275 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.333 B
COR NYSE Cencora Inc Fair Value Fair Market Cap 60.002 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 51.415 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 44.67 B
CNC NYSE Centene Corp Fair Value Undervalued Market Cap 31.27 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 25.911 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 25.266 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 23.774 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.101 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.111 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.925 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.79 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.716 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.567 B
ENSG NASDAQ The Ensign Group Inc Fair Value Fair Market Cap 10.19 B